×
-0.0096463022508038 -0.0096463022508038 -0.0096463022508038 -0.0096463022508038 -0.0096463022508038 0.0128617363344052 0.0128617363344052 0.0128617363344052
Stock impact report

Axsome Therapeutics to Focus on Growing Core CNS Portfolio; Establishes Axsome Pain and Primary Care Business Unit to Enhance Value of Non-CNS Assets

Axsome Therapeutics, Inc (AXSM)  More Company Research Source: GlobeNewswire
Last axsome therapeutics, inc earnings: 5/9 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: axsome.com
PDF Axsome PPC to include three novel, non-opioid, Phase 3-stage product candidates for chronic pain 145 issued Axsome PPC patents, including 21 covering neridronate, provide protection as far as 2036 Indications include osteoarthritis, osteoporosis, and complex regional pain syndrome   NEW YORK, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that it will focus on its growing core CNS portfolio. As a result, the Company has created Axsome Pain and Primary Care (Axsome PPC), a new business unit to house, manage, develop and enhance the value of Axsome’s non-CNS assets. The assets in Axsome PPC include the Company’s pain and primary care product candidates and related intellectual property. “The new corporate structure allows us to maintain focus on Axsome’s growing core CNS portfolio, and to position the non-C [Read more]
Impact snapshot Event time: AXSM
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
AXSM alerts
from News Quantified
Opt-in for
AXSM alerts

from News Quantified
Opt-in for
AXSM alerts

from News Quantified